Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

24-Jun-2011 - United Kingdom

Crescendo Biologics Limited announced the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing.

During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, and saw the corporation develop from an entrepreneurial start-up to a leading multi-national biotechnology company. He negotiated and managed multiple agreements for drug delivery technologies in the USA, Europe and Japan and was also a core team member on the divestment of Genzyme’s Pharmaceuticals business.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances